Published by Frank Prenesti on 19th March 2024
(Sharecast News) - AstraZeneca said it had agreed to buy biopharmaceutical company Fusion Pharmaceuticals for up to $2bn.
URL: http://www.digitallook.com/dl/news/story/34163936/...